Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline
Company reiterates focus on advancing ProLectin-M under an active FDA IND and progressing oxygen-transport programs for stroke and neurodegenerative disease
Read More